INTRAARTICULAR EPSILON AMINOCAPROIC ACID VERSUS TRANEXAMIC ACID IN TOTAL KNEE ARTHROPLASTY
Authors:
- Joao Paulo Fernandes GuerreiroJGJoao Paulo Fernandes Guerreiro
- Jose Rodolfo Martines BalbinoJBJose Rodolfo Martines Balbino
- Bruno Possani RodriguesBRBruno Possani Rodrigues
- Marcus Vinicius DanieliMDMarcus Vinicius Danieli
- Alexandre Oliveira QueirozAQAlexandre Oliveira Queiroz
- Daniele Cristina CataneoDCDaniele Cristina Cataneo
Open Access
- 1 December 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Acta Ortopedica Brasileira
- Vol. 29 (6) , 312-315
Abstract
Objective: To examine and compare the clinical efficacy of intraarticular epsilon aminocaproic acid (EACA) and tranexamic acid (TXA) in total knee arthroplasty (TKA). Methods: This study was a prospective, single-center, double-blinded randomized controlled trial, including sixty patients with osteoarthritis of the knee divided into two groups of 30 patients. In the TXA group, 1 g of TXA (0.05 g/ml) was applied intraarticularly, and in the EACA group, 4 g of EACA (0.2 g/ml) was applied intraarticularly. Serum hemoglobin (Hgb) and hematocrit (Htb) were measured during the preoperatively and 24 and 48 hours postoperatively. The range of motion and pain were evaluated by clinical examination. To evaluate knee function before and 2 months after surgery, the Western Ontario and McMaster Universities Index (WOMAC) questionnaire was used. Results: In total, 56 (93.3%) patients were evaluated up to the second postoperative month. No significant difference between the groups (p > 0.05) was found in the decrease in Hgb or Htb at 24 or 48 hours. Regarding assessment of the pain, WOMAC score and gain in knee flexion, no significant advantages up to 60 days after surgery (p > 0.05) were found. Conclusions: The decrease in Hgb and Htb during the first 48 hours postoperatively and the risk of transfusion were similar with the intraarticular use of 1 g of TXA and 4 g of EACA in TKA. The possible benefits regarding knee pain, gain in flexion and function were also similar for the two drugs. Level of Evidence II, Randomized, Double-Blinded, Single-Centre, Prospective Clinical Trial.Keywords
This publication has 13 references indexed in Scilit:
- Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled TrialsThe Journal of Knee Surgery, 2017
- Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee ArthroplastyThe Journal of Knee Surgery, 2016
- Using Aminocaproic Acid to Reduce Blood Loss After Primary Unilateral Total Knee Arthroplasty.2016
- Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysisKnee Surgery, Sports Traumatology, Arthroscopy, 2016
- Topical Tranexamic Acid May Improve Early Functional Outcomes of Primary Total Knee ArthroplastyThe Journal of Arthroplasty, 2016
- Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic reviewKnee Surgery, Sports Traumatology, Arthroscopy, 2013
- Efficacy of intra‐articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplastyKnee Surgery, Sports Traumatology, Arthroscopy, 2012
- Tranexamic acid in total knee replacementThe Journal of Bone and Joint Surgery. British volume, 2011
- Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trialBritish Journal of Anaesthesia, 2006
- Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteersEuropean Journal of Clinical Pharmacology, 1974